Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$80,876,372
+$32,973,831 QoQ
Shares Held
67,429
+29.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#424
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 71%
Shared 10%
None 19%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Savant Capital, LLC holds $304,795,936 across 15 Drug Manufacturers - General names. LLY ranks #1 (26.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
67,429 | $80,876,372 | |
| 2 | JNJ |
Johnson & Johnson
|
265,777 | $67,499,384 | |
| 3 | ABBV |
AbbVie Inc.
|
205,994 | $51,836,330 | |
| 4 | MRK |
Merck & Co., Inc.
|
220,270 | $28,304,695 | |
| 5 | NVS |
Novartis AG
|
150,968 | $23,659,704 | |
| 6 | AMGN |
Amgen Inc
|
40,234 | $14,569,536 | |
| 7 | PFE |
Pfizer Inc
|
423,589 | $10,200,023 | |
| 8 | AZN |
Astrazeneca PLC
|
35,321 | $6,697,568 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $80,876,372 | 67,429 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $47,902,541 | 52,081 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $51,793,132 | 48,194 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $37,165,730 | 48,710 | Shares | Sole | 2026-03-04 | |
| 2025-06-30 | $37,429,912 | 48,016 | Shares | Sole | 2026-03-04 | |
| 2025-03-31 | $37,735,827 | 45,690 | Shares | Sole | 2026-03-04 | |
| 2024-12-31 | $38,391,560 | 49,730 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $46,954,820 | 53,000 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $37,570,553 | 41,497 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $33,414,159 | 42,951 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $24,278,618 | 41,650 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $22,883,886 | 42,604 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $20,445,652 | 43,596 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $13,913,317 | 40,514 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $13,203,531 | 36,091 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $11,359,608 | 35,131 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $11,202,470 | 34,551 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $9,652,673 | 33,707 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $8,740,705 | 31,644 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $7,236,717 | 31,321 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,728,074 | 11,886 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,281,819 | 12,214 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $2,042,119 | 12,095 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,694,236 | 11,446 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $1,858,353 | 11,319 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,455,588 | 10,493 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||